Torthaí cuardaigh - Maureen Lundt
- 1 - 1 toradh as 1 á dtaispeáint
-
1
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease de réir Julia Xu, Anna Conrey, Ingrid Frey, Eveline Gwaabe, Laurel A. Menapace, Laxminath Tumburu, Maureen Lundt, Timothy Lequang, Quan Li, Kristen E. Glass, Emily B. Dunkelberger, Varsha Iyer, Heidi Mangus, Charles Kung, Lenny Dang, Penelope A. Kosinski, Peter Hawkins, Neal Jeffries, William A. Eaton, Swee Lay Thein
Foilsithe / Cruthaithe 2022Artigo